Felipe Melo-González

Dr. Felipe Melo-González

Universidad Andres Bello, Santiago, Región Metropolitana, Chile
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Immunity
Verified
Journal Article
Open access
JEJohanna Emgård
Johanna Emgård
HKHana Kammoun
Hana Kammoun
BGBethania García-Cassani
Bethania García-Cassani
JCJulie Chesné
Julie Chesné
SPSara M. Parigi
Sara M. Parigi
Tim WillingerTim Willinger
Tim Willinger
Group 3 innate lymphoid cells (ILC3s) sense environmental signals and are critical for tissue integrity in the intestine. Yet, which signals are sensed and what receptors control ILC3 function remain poorly understood. Here, we show that ILC3s with a lymphoid-tissue-inducer (LTi) phenotype expressed G-protein-coupled receptor 183 (GPR183) and migrated to its oxysterol ligand 7α,25-hydroxycholesterol (7α,25-OHC). In mice lacking Gpr183 or 7α,25-OHC, ILC3s failed to localize to cryptopatches (CPs) and isolated lymphoid follicles (ILFs). Gpr183 deficiency in ILC3s caused a defect in CP and ILF formation in the colon, but not in the small intestine. Localized oxysterol production by fibroblastic stromal cells provided an essential signal for colonic lymphoid tissue development, and inflammation-induced increased oxysterol production caused colitis through GPR183-mediated cell recruitment. Our findings show that GPR183 promotes lymphoid organ development and indicate that oxysterol-GPR183-dependent positioning within tissues controls ILC3 activity and intestinal homeostasis.

9 December 2016 in Immunology
Verified
Journal Article
Open access
PDF file
FMFelipe Melo-González
Felipe Melo-González
MHMatthew R. Hepworth
Matthew R. Hepworth
Summary: Group 3 innate lymphoid cells (ILC3), defined by expression of the transcription factor retinoid‐related orphan receptor γt, play key roles in the regulation of inflammation and immunity in the gastrointestinal tract and associated lymphoid tissues. ILC3 consist largely of two major subsets, NCR+ ILC3 and LTi‐like ILC3, but also demonstrate significant plasticity and heterogeneity. Recent advances have begun to dissect the relationship between ILC3 subsets and to define distinct functional states within the intestinal tissue microenvironment. In this review we discuss the ever‐expanding roles of ILC3 in the context of intestinal homeostasis, infection and inflammation – with a focus on comparing and contrasting the relative contributions of ILC3 subsets.

27 February 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
FMFelipe Melo-González
Felipe Melo-González
HKHana Kammoun
Hana Kammoun
EEElza Evren
Elza Evren
EDEmma E. Dutton
Emma E. Dutton
MPMarkella Papadopoulou
Markella Papadopoulou
MHMatthew R. Hepworth
Matthew R. Hepworth
Intestinal immune homeostasis is dependent upon tightly regulated and dynamic host interactions with the commensal microbiota. Immunoglobulin A (IgA) produced by mucosal B cells dictates the composition of commensal bacteria residing within the intestine. While emerging evidence suggests the majority of IgA is produced innately and may be polyreactive, mucosal-dwelling species can also elicit IgA via T cell–dependent mechanisms. However, the mechanisms that modulate the magnitude and quality of T cell–dependent IgA responses remain incompletely understood. Here we demonstrate that group 3 innate lymphoid cells (ILC3) regulate steady state interactions between T follicular helper cells (TfH) and B cells to limit mucosal IgA responses. ILC3 used conserved migratory cues to establish residence within the interfollicular regions of the intestinal draining lymph nodes, where they act to limit TfH responses and B cell class switching through antigen presentation. The absence of ILC3-intrinsic antigen presentation resulted in increased and selective IgA coating of bacteria residing within the colonic mucosa. Together these findings implicate lymph node resident, antigen-presenting ILC3 as a critical regulatory checkpoint in the generation of T cell–dependent colonic IgA and suggest ILC3 act to maintain tissue homeostasis and mutualism with the mucosal-dwelling commensal microbiota.

1 April 2016 in Immunity
Verified
Journal Article
Closed access
KLKatarzyna M. Luda
Katarzyna M. Luda
TJThorsten Joeris
Thorsten Joeris
EPEmma K. Persson
Emma K. Persson
ARAymeric Rivollier
Aymeric Rivollier
MDMimoza Demiri
Mimoza Demiri
WAWilliam W. Agace
William W. Agace

2 September 2022 in Science Immunology
Verified
Journal Article
Open access
HPHugo Penny
Hugo Penny
RDRita G. Domingues
Rita G. Domingues
MKMaria Z. Krauss
Maria Z. Krauss
FMFelipe Melo-González
Felipe Melo-González
MLMelissa Lawson
Melissa Lawson
MHMatthew R. Hepworth
Matthew R. Hepworth
Interactions between the mammalian host and commensal microbiota are enforced through a range of immune responses that confer metabolic benefits and promote tissue health and homeostasis. Immunoglobulin A (IgA) responses directly determine the composition of commensal species that colonize the intestinal tract but require substantial metabolic resources to fuel antibody production by tissue-resident plasma cells. Here, we demonstrate that IgA responses are subject to diurnal regulation over the course of a circadian day. Specifically, the magnitude of IgA secretion, as well as the transcriptome of intestinal IgA + plasma cells, was found to exhibit rhythmicity. Oscillatory IgA responses were found to be entrained by time of feeding and were also found to be in part coordinated by the plasma cell–intrinsic circadian clock via deletion of the master clock gene Arntl . Moreover, reciprocal interactions between the host and microbiota dictated oscillatory dynamics among the commensal microbial community and its associated transcriptional and metabolic activity in an IgA-dependent manner. Together, our findings suggest that circadian networks comprising intestinal IgA, diet, and the microbiota converge to align circadian biology in the intestinal tract and to ensure host-microbial mutualism.

23 June 2023 in Frontiers in Microbiology
Verified
Journal Article
Open access
SGSebastian Gatica
Sebastian Gatica
BFBrandon Fuentes
Brandon Fuentes
ERElizabeth Rivera-Asín
Elizabeth Rivera-Asín
PRPaula Ramírez-Céspedes
Paula Ramírez-Céspedes
JSJaviera Sepúlveda-Alfaro
Javiera Sepúlveda-Alfaro
FMFelipe Melo-González
Felipe Melo-González
Sepsis is a life-threatening condition and a significant cause of preventable morbidity and mortality globally. Among the leading causative agents of sepsis are bacterial pathogens Escherichia coli, Klebsiella pneumoniae, Staphylococcus aureus, Pseudomonas aeruginosa, and Streptococcus pyogenes, along with fungal pathogens of the Candida species. Here, we focus on evidence from human studies but also include in vitro and in vivo cellular and molecular evidence, exploring how bacterial and fungal pathogens are associated with bloodstream infection and sepsis. This review presents a narrative update on pathogen epidemiology, virulence factors, host factors of susceptibility, mechanisms of immunomodulation, current therapies, antibiotic resistance, and opportunities for diagnosis, prognosis, and therapeutics, through the perspective of bloodstream infection and sepsis. A list of curated novel host and pathogen factors, diagnostic and prognostic markers, and potential therapeutical targets to tackle sepsis from the research laboratory is presented. Further, we discuss the complex nature of sepsis depending on the sepsis-inducing pathogen and host susceptibility, the more common strains associated with severe pathology and how these aspects may impact in the management of the clinical presentation of sepsis.